1Joslin Diabetes Center, Harvard Medical School, Boston, Mass., USA. mark.williams@joslin.harvard.edu
Proteinuria is a key indicator in diabetic kidney disease. Reducing proteinuria may slow disease progression, supporting its use as a surrogate endpoint in clinical trials for diabetic nephropathy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: